Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Yoshitomi reports potent and selective tryptase inhibitors with oral activity

May 24, 1999

Ipratropium bromide may improve sleep, nocturnal oxygen in COPD patients

May 24, 1999

Different crystalline forms of cipamfylline studied at SB

May 21, 1999

Merck discloses potent, selective and orally active PDE4 inhibitors

May 21, 1999

Positive findings from phase III trial of anti-IgE for allergic rhinitis

May 19, 1999

Inflazyme signs collaborative agreement with HMR for asthma and allergy therapeutics

May 19, 1999

Johnson & Johnson withdraws from norastemizole collaboration

May 18, 1999

SmithKline Beecham describes new series of CCR5 receptor modulators

May 17, 1999

PathoGenesis launches TOBI in second market

May 13, 1999

Asahi Glass describes dual NK1/NK2 antagonists

May 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....